Patents by Inventor Kevin E. Brooks

Kevin E. Brooks has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Mycobacterium fortuitum mutant
    Patent number: 4358538
    Abstract: Mutant which is used in a novel microbiological process to selectively transform steroids having 17-alkyl side chains of from 2 to 10 carbon atoms, inclusive, to yield sole transformed product. AD is a valuable intermediate to make useful steroids.
    Type: Grant
    Filed: September 8, 1980
    Date of Patent: November 9, 1982
    Assignee: The Upjohn Company
    Inventors: Merle G. Wovcha, Kevin E. Brooks
  • Mycobacterium fortuitum mutant
    Patent number: 4345034
    Abstract: Mutant which is used in a novel microbiological process to selectively transform steroids having 17-alkyl side chains of from 2 to 10 carbon atoms, inclusive, to yield androst-4-ene-3,17-dione (AD) as essentially the sole transformed product. AD is a valuable intermediate to make useful steroids.
    Type: Grant
    Filed: August 8, 1980
    Date of Patent: August 17, 1982
    Assignee: The Upjohn Company
    Inventors: Merle G. Wovcha, Kevin E. Brooks
  • Composition of matter and process
    Patent number: 4293646
    Abstract: Mutant which is used in a novel microbiological process to selectively transform steroids having 17-alkyl side chains of from 2 to 10 carbon atoms, inclusive, to yield androst-4-ene-3,17-dione (AD) as essentially the sole transformed product. AD is a valuable intermediate to make useful steroids.
    Type: Grant
    Filed: August 7, 1978
    Date of Patent: October 6, 1981
    Assignee: The Upjohn Company
    Inventors: Merle G. Wovcha, Kevin E. Brooks